Skip to main content

Table 2 The diagnostic accuracy of biomarkers for early detection of HCC

From: VWF/ADAMTS13 ratio as a potential biomarker for early detection of hepatocellular carcinoma

Variable

OR (95% CI)

P value

Unvariable analysis

 AFP > 10 ng/mL

1.01 (0.98–1.05)

0.49

 DCP > 40mAU/mL

5.48 (1.10–27.3)

0.038

 AFP-L3% > 5%

15.9 (1.89–134.0)

0.011

 VEGF > 100 pg/mL

7.06 (1.39–35.9)

0.019

 VEGFR2 > 6500 pg/mL

2.46 (0.796–7.63)

0.12

 ADAMTS13:AC > 60%

0.31 (0.0874–1.10)

0.082

 VWF:Ag > 300%

4.31 (1.30–14.3)

0.017

 VWF:Ag/ADAMTS13:AC > 5

8.95 (1.82–44.0)

0.007

Multivariable analysis

 AFP-L3% > 5%

19.5 (1.78–214.0)

0.015

 VWF:Ag/ADAMTS13:AC > 5

18.5 (1.64–209.0)

0.018

  1. HCC hepatocellular carcinoma, AFP alpha fetoprotein, DCP des-γ-carboxy prothrombin
  2. AFP-L3%, Lens culinaris agglutinin-reactive alpha-fetoprotein
  3. VEGF, vascular endothelial growth factor; VEGFR-2, VEGF receptor-2
  4. ADAMTS13, a disintegrin-like and metalloproteinase with thrombospondin type 1 motifs 13
  5. VWF, von Willebrand factor; ADAMTS13:AC, ADAMTS13 activity
  6. VWF:Ag, von Willebrand factor antigen; VWF:Ag/ADAMTS13:AC, ratio of VWF:Ag to ADAMTS13:AC. CI, confidence interval; OR, odds ratio